Join
Live feed
·
PRReleasevia Quantisnow
LeonaBio Inc. logo

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

ByQuantisnow·Wall Street's wire, on your screen.
LONA· LeonaBio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LONA (LeonaBio Inc.) and more on Quantisnow.